|
|
Daisy LabUpdatedProfile date: 2026-06-04 Company Profile: Daisy LabExecutive SummaryDaisy Lab is an innovative biotechnology and agricultural technology (AgriTech) company headquartered in Auckland, New Zealand. Founded in 2021, the company operates in the rapidly growing field of cellular agriculture, focusing specifically on precision fermentation. Daisy Lab's primary objective is to produce dairy-identical proteins without the need for intensive livestock farming. By utilizing genetically optimized microorganisms, the company aims to offer a sustainable, scalable, and ethical alternative to traditional dairy production, positioning itself as a key player in the transition toward a more resilient global food system. Continue…Core Technology: Precision FermentationAt the core of Daisy Lab's operations is precision fermentation—a process that programs microflora, such as yeast or fungi, to act as cell factories that express specific proteins. The Scientific Process
This process completely bypasses the biological inefficiencies of a cow, reducing greenhouse gas emissions, land footprint, and water usage by up to 90% compared to traditional dairy farming. Products and Services PortfolioDaisy Lab operates as a Business-to-Business (B2B) ingredient supplier, providing raw dairy-identical proteins to consumer packaged goods (CPG) companies, food manufacturers, and industrial dairy processors. 1. Recombinant Casein ProteinsCasein makes up approximately 80% of the protein content in bovine milk and is crucial for the physical structure of dairy products. Unlike plant proteins, casein has the unique ability to form micelles—complex molecular structures that trap water and fat, allowing cheese to melt, stretch, and emulsify. * Alpha-Casein, Beta-Casein, and Kappa-Casein: Daisy Lab targets the expression of these major casein variants. * Target Applications: The primary application for Daisy Lab’s casein is the manufacture of animal-free, real-dairy cheeses (such as mozzarella, cheddar, and cream cheese) that exhibit the exact stretch and melt profiles consumers expect from cow-derived cheese. It is also used to formulate animal-free yogurts and milks. 2. Recombinant Whey ProteinsWhey represents the remaining 20% of milk protein and is widely used for its nutritional value and functional gelling properties. * Beta-Lactoglobulin: This is the dominant whey protein produced via Daisy Lab’s yeast platform. * Target Applications: Beta-lactoglobulin is highly soluble and heat-stable, making it ideal for sports nutrition formulas, protein powders, protein bars, RTD (Ready-to-Drink) beverages, and specialized nutritional products. 3. LactoferrinLactoferrin is a high-value, iron-binding glycoprotein naturally found in milk. It is prized for its immune-supporting, anti-inflammatory, and antimicrobial properties. * Target Applications: Lactoferrin is a premium ingredient used primarily in infant formula, dietary supplements, and functional health foods. Producing it via precision fermentation offers a highly purified, consistent supply unaffected by seasonal milk variations. 4. Collaborative R&D and Co-Development ServicesIn addition to supplying bulk ingredients, Daisy Lab partners with established food manufacturers and scientific institutions to co-develop custom formulations. * Strain Customization: Optimizing host organisms to express specific protein profiles or yields tailored to a partner's requirements. * Process Scale-up Consulting: Leveraging Daisy Lab’s bioprocess engineering expertise to help food processors transition from pilot-scale production to commercial manufacturing. Market Positioning and Strategic ValueNew Zealand is one of the world's largest exporters of pastoral dairy products. Daisy Lab positions itself as a complementary partner to this heritage, offering a path for New Zealand to retain its status as a global leader in high-value protein export while addressing the pressing environmental challenges associated with intensive pastoral farming. Key Value Propositions
Growth, Funding, and MilestonesDaisy Lab has successfully secured venture capital backing from prominent domestic and international investors, including Icehouse Ventures, Outset Ventures, and the Booster Innovation Fund. The company has successfully scaled its technology from laboratory bench scale to multi-liter pilot bioreactors. Daisy Lab has demonstrated the functional viability of its proteins by producing prototypes of animal-free cheese and dairy products that perform identically to traditional counterparts. The company’s ongoing focus is optimizing expression yields to lower production costs, driving toward price parity with conventional dairy proteins on the global commodity market.
Copyright © 2026 Computer Review. All Rights Reserved.
COMPUTER REVIEW • Gloucester, MA 01930 • (978) 283-2100 • info@computerreview.com |
|